Zentalis Pharmaceuticals (ZNTL) Restructuring Costs (2025)

Zentalis Pharmaceuticals' Restructuring Costs history runs 1 years deep, the most recent figure standing at $7.8 million for Q1 2025.

• In Q1 2025, Restructuring Costs changed N/A year-over-year to $7.8 million; the TTM figure through Dec 2025 stood at $7.8 million (changed N/A YoY), while the FY2025 annual figure was $7.8 million, changed N/A from the prior year.
• Restructuring Costs for Q1 2025 stood at $7.8 million.
• The five-year high for Restructuring Costs was $7.8 million in Q1 2025, with the low at $7.8 million in Q1 2025.